Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avid Bioservices Initiates Lab Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Avid Bioservices Initiates Lab Expansion

Newly constructed lab will ultimately provide an additional 3,000 sq.-ft. of process development capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avid Bioservices, a CDMO focused on biopharmaceutical products derived from mammalian cell culture, has advanced the ongoing expansion of its process development capabilities and labs, initiating demolition work at the site that will ultimately provide an additional 3,000 sq.-ft. of space.

The newly constructed lab will allow for the consolidation of cell line development, upstream process development and upstream pilot scale production in a single location with the latest equipment.  Once complete, this facility will be used for on-boarding new clients for the delivery of robust, compliant, viable biologics manufacturing processes and executing technology transfer of existing processes. Avid’s cell culture development also includes a range of purification and analytical development services.
 
Some additional plans for the lab include: bioreactor development and control systems, a higher level of automation and reporting capabilities, the tripling of the current capacity provided by benchtop bioreactor systems, as well as the hiring of additional process development scientists.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters